LGALS1 and Parkinson disease: Huang et al. indicated the CD45-galectin-1 interaction between Tregs and MN9D cells prevented MPP+ toxicity and reduce the neuron losses in MPTP-induced Parkinson’s Disease mice with exogenous administration of Tregs [40].